5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed October 10, 2022.
- IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed October 10, 2022.
- Azilsartan tablets (Edarbi®) package insert. Arbor Pharmaceuticals, March 2020.
- Candesartan tablets (Atacand®) package insert. ANI Pharmaceuticals, Inc., June 2020.
- Irbesartan tablets (Avapro®) package insert. Sanofi-Aventis U.S., September 2021.
- Losartan tablets (Cozaar®) package insert. Organon, October 2021.
- Olmesartan tablets (Benicar®) package insert. Cosette Pharmaceuticals, Inc., February 2022.
- Telmisartan tablets (Micardis®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., July 2020.
- Valsartan tablets (Diovan®) package insert. Novartis Pharmaceuticals Corporation, April 2021.
- Valsartan oral solution package insert. Lifsa Drugs, April 2022.
- Losartan/hydrochlorothiazide tablets (Hyzaar®) package insert. Organon, June 2021.
- Sacubitril/valsartan tablets (Entresto®) package insert. Novartis Pharmaceuticals Corporation, February 2021.
- Amlodipine/Olmesartan tablets (Azor®) package insert. Cosette Pharmaceuticals, Inc., February 2022.
- Amlodipine/valsartan tablets (Exforge®) package insert. Novartis Pharmaceuticals Corporation, April 2021.
- Amlodipine/valsartan/hydrochlorothiazide tablets (Exforge HCT®) package insert. Novartis Pharmaceuticals Corportation, February 2021.
- Azilsartan/chlorthalidone tablets (Edarbyclor®) package insert. Arbor Pharmaceuticals, March 2020.
- Candesartan/hydrochlorothiazide tablets (Atacand HCT®) package insert. ANI Pharmaceuticals, Inc., May 2020.
- Irbesartan/hydrochlorothiazide tablets (Avalide®) package insert. Sanofi-Aventis U.S., September 2021.
- Olmesartan/amlodipine/hydrochlorothiazide tablets (Tribenzor®) package insert. Cosette Pharmaceuticals, Inc., February 2022.
- Olmesartan/hydrochlorothiazide tablets (Benicar HCT®) package insert. Cosette Pharmaceuticals, Inc., February 2022.
- Telmisartan/amlodipine tablets package insert. Torrent Pharmaceuticals, March 2022.
- Telmisartan/hydrochlorothiazide tablets (Micardis HCT®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., August 2020.
- Valsartan/hydrochlorothiazide tablets (Diovan HCT®) package insert. Novartis Pharmaceuticals Corporation, August 2020.
- The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-59.
- Phillips CO, Kashani A, Ko DK, et al. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction. A quantitative review of data from randomized clinical trials. Arch Intern Med. 2007;167:1930-6.
- Heidenreich P, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022 May, 79 (17) e263–e421.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71:e127-e248.
- Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-e228.